Mental Health Repository

INSTITUTION'S PROFILE

Azienda Ospedaliera di Rilievo Nazionale San Giuseppe Moscati Avellino, Avellino, Italy.

Publications (8)

Explainable time-to-progression predictions in multiple sclerosis.

Journal: Computer methods and programs in biomedicine

Publication Year:

Authors & Co-authors: D'hondt Robbe R Dedja Klest K Aerts Sofie S Van Wijmeersch Bart B Kalincik Tomas T Reddel Stephen S Havrdova Eva Kubala EK Lugaresi Alessandra A Weinstock-Guttman Bianca B Mrabet Saloua S

Machine-learning-based prediction of disability progression in multiple sclerosis: An observational, international, multi-center study.

Journal: PLOS digital health

Publication Year:

Authors & Co-authors: De Brouwer Edward E Becker Thijs T Werthen-Brabants Lorin L Dewulf Pieter P Iliadis Dimitrios D Dekeyser Cathérine C Laureys Guy G Van Wijmeersch Bart B Popescu Veronica V Dhaene Tom T

A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic.

Journal: Journal of neurology

Publication Year:

Authors & Co-authors: Lal Anoushka P AP Foong Yi Chao YC Sanfilippo Paul G PG Spelman Tim T Rath Louise L Levitz David D Fabis-Pedrini Marzena M Foschi Matteo M Habek Mario M Kalincik Tomas T

Early clinical markers of aggressive multiple sclerosis.

Journal: Brain : a journal of neurology

Publication Year: 2020

Authors & Co-authors: Malpas Charles B CB Manouchehrinia Ali A Sharmin Sifat S Roos Izanne I Horakova Dana D Havrdova Eva Kubala EK Trojano Maria M Izquierdo Guillermo G Eichau Sara S Bergamaschi Roberto R

Comparative effectiveness in multiple sclerosis: A methodological comparison.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication Year: 2023

Authors & Co-authors: Roos Izanne I Diouf Ibrahima I Sharmin Sifat S Horakova Dana D Havrdova Eva Kubala EK Patti Francesco F Shaygannejad Vahid V Ozakbas Serkan S Izquierdo Guillermo G Eichau Sara S

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Publication Year: 2023

Authors & Co-authors: Daruwalla Cyrus C Shaygannejad Vahid V Ozakbas Serkan S Havrdova Eva Kubala EK Horakova Dana D Alroughani Raed R Boz Cavit C Patti Francesco F Onofrj Marco M Lugaresi Alessandra A

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.

Journal: JAMA neurology

Publication Year: 2023

Authors & Co-authors: Kalincik Tomas T Sharmin Sifat S Roos Izanne I Freedman Mark S MS Atkins Harold H Burman Joachim J Massey Jennifer J Sutton Ian I Withers Barbara B Macdonell Richard R

Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.

Journal: Journal of medical economics

Publication Year: 2023

Authors & Co-authors: Spelman T T Herring W L WL Acosta C C Hyde R R Jokubaitis V G VG Pucci E E Lugaresi A A Laureys G G Havrdova E K EK Horakova D D